PTPaul Kwong Hang Tam

Paul Kwong Hang Tam

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul Kwong Hang Tam has a total of 207 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Meta-analysis of two Chinese populations identifies an autoimmune disease risk allele in 22q11.21 as associated with systemic lupus erythematosus

    by Yan Zhang, Yong-Fei Wang, Jing Yang, Jing Zhang, Liangdan Sun, Nattiya Hirankarn, Hai-Feng Pan, Chak Sing Lau, Tak Mao Chan, Tsz Leung Lee, et al.


  • Open Access

    Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2

    by Maria-Mercè Garcia-Barceló, Ming-Yiu Yeung, Xiao-Ping Miao, Clara Sze-Man Tang, Guo Chen, Man-Ting So, Elly Sau-Wai Ngan, Vincent Chi-Hang Lui, Yan Chen, Xue-Lai Liu, et al.

    Biliary atresia (BA) is characterized by the progressive fibrosclerosing obliteration of the extrahepatic biliary system during the first few weeks of life. Despite early diagnosis and prompt surgical intervention, the disease progresses to cirrhosis in many patients. The current theory for the pathogenesis of BA proposes that during the perinatal period, a still unknown exogenous factor meets the innate immune system of a genetically predisposed individual and induces an uncontrollable and potentially self-limiting immune response, which becomes manifest in liver fibrosis and atresia of the extrahepatic bile ducts. Genetic factors that could account for the disease, let alone for its high incidence in Chinese, are to be investigated. To identify BA susceptibility loci, we carried out a genome-wide association study (GWAS) using the Affymetrix 5.0 and 500 K marker sets. We genotyped nearly 500 000 single-nucleotide polymorphisms (SNPs) in 200 Chinese BA patients and 481 ethnically matched control subjects. The 10 most BA-associated SNPs from the GWAS were genotyped in an independent set of 124 BA and 90 control subjects. The strongest overall association was found for rs17095355 on 10q24, downstream XPNPEP1, a gene involved in the metabolism of inflammatory mediators. Allelic chi-square test P-value for the meta-analysis of the GWAS and replication results was 6.94 × 10−9. The identification of putative BA susceptibility loci not only opens new fields of investigation into the mechanisms underlying BA but may also provide new clues for the development of preventive and curative strategies.


  • Genetic basis of Hirschsprung’s disease

    by Paul K. H. Tam, Mercè Garcia-Barceló

    Hirschsprung’s disease (HSCR) is a developmental disorder characterized by the absence of ganglion cells in the lower digestive tract. Aganglionosis is attributed to a disorder of the enteric nervous system (ENS) whereby ganglion cells fail to innervate the lower gastrointestinal tract during embryonic development. HSCR is a complex disease that results from the interaction of several genes and manifests with low, sex-dependent penetrance and variability in the length of the aganglionic segment. The genetic complexity observed in HSCR can be conceptually understood in light of the molecular and cellular events that take place during the ENS development. DNA alterations in any of the genes involved in the ENS development may interfere with the colonization process, and represent a primary etiology for HSCR. This review will focus on the genes known to be involved in HSCR pathology, how they interact, and on how technology advances are being employed to uncover the pathological processes underlying this disease.


  • A novel function for dendritic cell: Clearance of VEGF via VEGF receptor-1

    by Yi Xie, Jianqing Fan, Juhua Chen, Fang-Ping Huang, Brian Cao, Paul K.H. Tam, Yi Ren


  • Open Access

    Genome-wide association study identifies NRG1 as a susceptibility locus for Hirschsprung's disease

    by Maria-Mercè Garcia-Barcelo, Clara Sze-Man Tang, Elly Sau-Wai Ngan, Vincent Chi-Hang Lui, Yan Chen, Man-Ting So, Thomas Yuk-Yu Leon, Xiao-Ping Miao, Cathy Ka-Yee Shum, Feng-Qin Liu, et al.

    Hirschsprung's disease (HSCR), or aganglionic megacolon, is a congenital disorder characterized by the absence of enteric ganglia in variable portions of the distal intestine. RET is a well-established susceptibility locus, although existing evidence strongly suggests additional loci contributing to sporadic HSCR. To identify these additional genetic loci, we carried out a genome-wide association study using the Affymetrix 500K marker set. We successfully genotyped 293,836 SNPs in 181 Chinese subjects with sporadic HSCR and 346 ethnically matched control subjects. The SNPs most associated with HSCR were genotyped in an independent set of 190 HSCR and 510 control subjects. Aside from SNPs in RET , the strongest overall associations in plausible candidate genes were found for 2 SNPs located in intron 1 of the neuregulin1 gene ( NRG1 ) on 8p12, with rs16879552 and rs7835688 yielding odds ratios of 1.68 [CI 95% :(1.40, 2.00), P = 1.80 × 10 −8 ] and 1.98 [CI 95% :(1.59, 2.47), P = 1.12 × 10 −9 ], respectively, for the heterozygous risk genotypes under an additive model. There was also a significant interaction between RET and NRG1 ( P = 0.0095), increasing the odds ratio 2.3-fold to 19.53 for the RET rs2435357 risk genotype (TT) in the presence of the NRG1 rs7835688 heterozygote, indicating that NRG1 is a modifier of HSRC penetrance. Our highly significant association findings are backed-up by the important role of NRG1 as regulator of the development of the enteric ganglia precursors. The identification of NRG1 as an additional HSCR susceptibility locus not only opens unique fields of investigation into the mechanisms underlying the HSCR pathology, but also the mechanisms by which a discrete number of loci interact with each other to cause disease.


  • Combined treatment with triptolide and rapamycin prolongs graft survival in a mouse model of cardiac transplantation

    by Yan Liu, Yan Chen, Fing Qin Liu, Jonathan R. Lamb, Paul K. H. Tam

    Current immunosuppressive strategies for transplantation have failed to achieve long-term graft survival. In this study, we investigate the effects of combined treatment with triptolide (TPT) and rapamycin (Rapa) on graft survival as well as changes in pathology and immunological responses. Heterotopic heart transplantation was performed. TPT and Rapa were administered either alone or in combination. The mean survival time (MST) for the cardiac allografts in animals receiving the combination of TPT and Rapa was 93.5 +/- 6.7 days compared to treatment with TPT (MST: 23.5 +/- 5.3 days), Rapa (22 +/- 1.3 days) alone or no treatment (7.66 +/- 0.8 days). Histopathological evaluation showed that inflammatory cell infiltration was markedly reduced in grafts with combined treatment groups. Down-regulation of CCL19, CCR5, CCR7, interferon gamma and interleukin (IL)-12 in the combination treatment was accompanied by increased expression of IL-4, IL-10 and CD4(+)CD25(+)Foxp3(+) regulatory T (Tr) cells in spleen. Finally, dendritic cell (DC) maturation was impaired by treatment with TPT/Rapa. Our results demonstrate that combination therapy with TPT and Rapa markedly prolongs cardiac allograft survival. This effect is accompanied by inhibition of DCs maturation, conditioning DCs to adopt tolerogenic phenotype, and the expansion of Tr cells. These results add weight to the application of combination therapy in transplantation.


  • Open Access

    Mapping of a Hirschsprung's disease locus in 3p21

    by Maria-Mercè Garcia-Barceló, Pui-Yee Fong, Clara S Tang, Xiao-Ping Miao, Man-Ting So, Zhen-Wei Yuan, Long Li, Wei-Hong Guo, Lei Liu, Bin Wang, et al.


  • Retracted

    Evaluation of the NK2 Homeobox 1 Gene ( NKX2‐1 ) as a Hirschsprung's Disease Locus THIS ARTICLE HAS BEEN RETRACTED

    by M.‐M. Garcia‐Barceló, D. K. Lau, E. S. Ngan, T. Y. Leon, T. Liu, M. So, X. Miao, V. C. Lui, K. K. Wong, R. W. Ganster, et al.


  • Evaluation of the Thyroid Transcription Factor‐1 Gene (TITF1) as a Hirschsprung's Disease Locus

    by Maria‐Mercè Garcia‐Barceló, Danny Ko‐Chun Lau, Elly Sau‐Wai Ngan, Thomas Yuk‐Yu Leon, Ting‐Ting Liu, Man‐Ting So, Xiao‐Ping Miao, Vincent Chi‐Hang Lui, Kenneth Kak‐Yuen Wong, Raymond William Ganster, et al.

    Summary: Hirschsprung's disease (HSCR, colonic aganglionosis) is an oligogenic entity that usually requires mutations in RET and other interacting loci. Decreased levels of RET expression may lead to the manifestation of HSCR. We previously showed that RET transcription was decreased due to alteration of the TITF1 binding site by two HSCR‐associated RET promoter single nucleotide polymorphisms (SNPs). This prompted us to investigate whether DNA alterations in TITF1 could play a role in HSCR by affecting the RET‐regulatory properties of the TITF1 protein. Our initial study on 86 Chinese HSCR patients revealed a Gly322Ser amino acid substitution in the TITF1protein. In this study we have examined an additional 102 Chinese and 70 Caucasian patients, and 194 Chinese and 60 Caucasian unselected, unrelated, subjects as controls. The relevance of the DNA changes detected in TITF1 by direct sequencing were evaluated using bioinformatics, reporter and binding‐assays, mouse neurosphere culture, immunohistochemistry and immunofluorescence techniques. Met3Leu and Pro48Pro were identified in 2 Caucasian patients and 1 Chinese patient, respectively. In vitro analysis showed that Met3Leu reduced the activity of the RET promoter by 100% in the presence of the wild‐type or HSCR‐associated RET promoter SNP alleles. The apparent binding affinity of the TITF1 mutated protein was not decreased. The Met3Leu mutation may affect the interaction of TITF1 with its protein partners. The absence of Titf1 expression in mouse gut but not in human gut suggests that the role of TITF1 in gut development differs between the two species. TITF1 mutations could contribute to HSCR by affecting RET expression through defective interactions with other transcription factors.